↓ Skip to main content

Treatment of cyclic vomiting syndrome with co-enzyme Q10 and amitriptyline, a retrospective study

Overview of attention for article published in BMC Neurology, January 2010
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (87th percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

twitter
3 X users
patent
1 patent
facebook
2 Facebook pages
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
73 Dimensions

Readers on

mendeley
68 Mendeley
citeulike
3 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Treatment of cyclic vomiting syndrome with co-enzyme Q10 and amitriptyline, a retrospective study
Published in
BMC Neurology, January 2010
DOI 10.1186/1471-2377-10-10
Pubmed ID
Authors

Richard G Boles, Mary R Lovett-Barr, Amy Preston, B UK Li, Kathleen Adams

Abstract

Cyclic vomiting syndrome (CVS), which is defined by recurrent stereotypical episodes of nausea and vomiting, is a relatively-common disabling condition that is associated with migraine headache and mitochondrial dysfunction. Co-enzyme Q10 (Co-Q) is a nutritional supplement that has demonstrated efficacy in pediatric and adult migraine. It is increasingly used in CVS despite the complete lack of studies to demonstrate its value in treatment

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 68 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 3 4%
Sri Lanka 1 1%
Italy 1 1%
Canada 1 1%
Unknown 62 91%

Demographic breakdown

Readers by professional status Count As %
Other 9 13%
Student > Master 9 13%
Student > Postgraduate 8 12%
Researcher 7 10%
Student > Bachelor 6 9%
Other 20 29%
Unknown 9 13%
Readers by discipline Count As %
Medicine and Dentistry 31 46%
Psychology 10 15%
Nursing and Health Professions 3 4%
Agricultural and Biological Sciences 3 4%
Biochemistry, Genetics and Molecular Biology 2 3%
Other 6 9%
Unknown 13 19%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 November 2020.
All research outputs
#3,613,478
of 22,729,647 outputs
Outputs from BMC Neurology
#438
of 2,424 outputs
Outputs of similar age
#21,212
of 164,628 outputs
Outputs of similar age from BMC Neurology
#1
of 10 outputs
Altmetric has tracked 22,729,647 research outputs across all sources so far. Compared to these this one has done well and is in the 84th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,424 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.7. This one has done well, scoring higher than 81% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 164,628 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 10 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them